Skip to main content
Top
Published in: Gastric Cancer 1/2014

01-01-2014 | Original Article

Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach

Authors: Kyoung-Joo Kwon, Ki-Nam Shim, Eun-Mi Song, Ju-Young Choi, Seong-Eun Kim, Hye-Kyung Jung, Sung-Ae Jung

Published in: Gastric Cancer | Issue 1/2014

Login to get access

Abstract

Background

Signet ring cell carcinoma (SRC) of the stomach is a histological type based on microscopic characteristics. Although the distinctive clinicopathological features of SRC have been reported, results are inconsistent and survival outcomes are uncertain.

Methods

We retrospectively studied 769 patients with gastric carcinoma who underwent gastrectomy in our institute from 1999 to 2009. Among them, 326 patients (42.4 %) had early gastric cancer (EGC) and 443 patients (57.6 %) had advanced gastric cancer (AGC). Sex, age, tumor location, macroscopic type, tumor size, microscopic invasion, and survival rate were compared between patients with SRC, differentiated-, and undifferentiated-type gastric carcinomas.

Results

Fifty-one patients (15.6 %) had SRC in EGC; there were significant differences in sex, age, location, macroscopic type, and size between SRC and the differentiated histological type. However, there was no difference between SRC and undifferentiated-type gastric carcinoma, except for the macroscopic type. Fifty-seven patients (12.9 %) had SRC in AGC. Sex, age, location, size, macroscopic type, perineural invasion, N stage, and hepatic metastasis were significantly different between SRC and the differentiated histological type. Undifferentiated-type gastric carcinoma differed in sex, macroscopic type, and hepatic metastasis. The overall survival rate differed between SRC and other cell types (P < 0.001). Among all the study patients, age [hazard ratio (HR) 1.013, P = 0.041] and tumor, node, and metastasis (TNM) stage (HR 2.350, P < 0.001) were important factors for predicting survival. Omitting patients with palliative resection or metastases, TNM stage was still an important factor for survival (HR 2.077, P < 0.001).

Conclusions

Patients with SRC showed similar clinicopathological features with undifferentiated histology. The survival of patients with SRC reflected a better prognosis in patients with undifferentiated gastric carcinoma. However, when narrowing the patients to those with EGC only, survival in EGC patients exhibited no difference between histological types. Among AGC patients, SRC patients had a worse prognosis than other cell types.
Literature
1.
go back to reference Jiang CG, Wang ZN, Sun Z, Liu FN, Yu M, Xu HM. Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional study. J Surg Oncol. 2011;103(7):700–3. doi:10.1002/jso.21878.PubMedCrossRef Jiang CG, Wang ZN, Sun Z, Liu FN, Yu M, Xu HM. Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional study. J Surg Oncol. 2011;103(7):700–3. doi:10.​1002/​jso.​21878.PubMedCrossRef
2.
3.
go back to reference Zhang M, Zhu G, Zhang H, Gao H, Xue Y. Clinicopathologic features of gastric carcinoma with signet ring cell histology. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2010;14(4):601–6. doi:10.1007/s11605-009-1127-9.CrossRef Zhang M, Zhu G, Zhang H, Gao H, Xue Y. Clinicopathologic features of gastric carcinoma with signet ring cell histology. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2010;14(4):601–6. doi:10.​1007/​s11605-009-1127-9.CrossRef
4.
go back to reference Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg. 2009;250(6):878–87. doi:10.1097/SLA.0b013e3181b21c7b.PubMedCrossRef Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg. 2009;250(6):878–87. doi:10.​1097/​SLA.​0b013e3181b21c7b​.PubMedCrossRef
6.
go back to reference Kim JP, Kim SC, Yang HK. Prognostic significance of signet ring cell carcinoma of the stomach. Surg Oncol. 1994;3(4):221–7.PubMedCrossRef Kim JP, Kim SC, Yang HK. Prognostic significance of signet ring cell carcinoma of the stomach. Surg Oncol. 1994;3(4):221–7.PubMedCrossRef
8.
go back to reference Lee JH, Choi IJ, Kook MC, Nam BH, Kim YW, Ryu KW. Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology. Br J Surg. 2010;97(5):732–6. doi:10.1002/bjs.6941.PubMedCrossRef Lee JH, Choi IJ, Kook MC, Nam BH, Kim YW, Ryu KW. Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology. Br J Surg. 2010;97(5):732–6. doi:10.​1002/​bjs.​6941.PubMedCrossRef
10.
go back to reference Theuer CP, Nastanski F, Brewster WR, Butler JA, Anton-Culver H. Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. Am Surgeon. 1999;65(10):915–21.PubMed Theuer CP, Nastanski F, Brewster WR, Butler JA, Anton-Culver H. Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. Am Surgeon. 1999;65(10):915–21.PubMed
11.
go back to reference Kim HM, Pak KH, Chung MJ, Cho JH, Hyung WJ, Noh SH, et al. Early gastric cancer of signet ring cell carcinoma is more amenable to endoscopic treatment than is early gastric cancer of poorly differentiated tubular adenocarcinoma in select tumor conditions. Surg Endosc. 2011;25(9):3087–93. doi:10.1007/s00464-011-1674-5.PubMedCrossRef Kim HM, Pak KH, Chung MJ, Cho JH, Hyung WJ, Noh SH, et al. Early gastric cancer of signet ring cell carcinoma is more amenable to endoscopic treatment than is early gastric cancer of poorly differentiated tubular adenocarcinoma in select tumor conditions. Surg Endosc. 2011;25(9):3087–93. doi:10.​1007/​s00464-011-1674-5.PubMedCrossRef
13.
go back to reference Kitaoka H. Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach. Gan To Kagaku Ryoho (Cancer Chemother). 1983;10(12):2453–60. Kitaoka H. Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach. Gan To Kagaku Ryoho (Cancer Chemother). 1983;10(12):2453–60.
15.
16.
go back to reference Ryu WS, Kim JH, Jang YJ, Park SS, Um JW, Park SH, et al. Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol. 2012;. doi:10.1002/jso.23097. Ryu WS, Kim JH, Jang YJ, Park SS, Um JW, Park SH, et al. Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol. 2012;. doi:10.​1002/​jso.​23097.
17.
go back to reference Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today. 1992;22(5):421–5.PubMedCrossRef Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today. 1992;22(5):421–5.PubMedCrossRef
18.
go back to reference Otsuji E, Yamaguchi T, Sawai K, Takahashi T. Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol. 1998;67(4):216–20.PubMedCrossRef Otsuji E, Yamaguchi T, Sawai K, Takahashi T. Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol. 1998;67(4):216–20.PubMedCrossRef
20.
go back to reference Hyung WJ, Noh SH, Lee JH, Huh JJ, Lah KH, Choi SH, et al. Early gastric carcinoma with signet ring cell histology. Cancer (Phila). 2002;94(1):78–83.CrossRef Hyung WJ, Noh SH, Lee JH, Huh JJ, Lah KH, Choi SH, et al. Early gastric carcinoma with signet ring cell histology. Cancer (Phila). 2002;94(1):78–83.CrossRef
21.
go back to reference Baik SH, Huang WJ, Lee JH, Lee KY, Noh SH, Min JS. The clinicopathologic characteristics and prognosis of gastric signet ring cell carcinoma. J Korean Surg Soc. 2000;59(6):771–7 Baik SH, Huang WJ, Lee JH, Lee KY, Noh SH, Min JS. The clinicopathologic characteristics and prognosis of gastric signet ring cell carcinoma. J Korean Surg Soc. 2000;59(6):771–7
22.
go back to reference Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228(4):449–61.PubMedCrossRef Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228(4):449–61.PubMedCrossRef
23.
go back to reference Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg. 1997;84(12):1651–64.PubMedCrossRef Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg. 1997;84(12):1651–64.PubMedCrossRef
Metadata
Title
Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach
Authors
Kyoung-Joo Kwon
Ki-Nam Shim
Eun-Mi Song
Ju-Young Choi
Seong-Eun Kim
Hye-Kyung Jung
Sung-Ae Jung
Publication date
01-01-2014
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2014
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-013-0234-1

Other articles of this Issue 1/2014

Gastric Cancer 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.